trending Market Intelligence /marketintelligence/en/news-insights/trending/-BQEqoJcs3FjVT29EwDUJg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Boston Scientific signs $700M loan agreement

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Boston Scientific signs $700M loan agreement

Boston Scientific Corp. entered a $700 million credit agreement with certain lenders.

The agreement provides for a $700 million 364-day term loan that will mature Dec. 3, 2020, at the London interbank offered rate plus a margin of 0.65%.

The Marlborough, Mass.-based medical device maker said in an SEC filing the loan will be used to repay the remaining amounts outstanding under an earlier $2 billion credit agreement, among other things.

Boston Scientific is required to maintain a maximum leverage ratio of 3.75x, among other things as part of the new credit arrangement.

Wells Fargo Bank NA is the syndication agent, while Bank of Nova Scotia and Wells Fargo Securities LLC are joint lead arrangers and joint book runners. Bank of Nova Scotia is also serving as administrative agent.